Pharmabiz

GSK’s Arexvy associated with reductions in certain RSV-related risks including heart attack, stroke and severe flare-ups of COPD and asthma, real world study shows

GSK’s Arexvy associated with reductions in certain RSV-related risks including heart attack, stroke and severe flare-ups of COPD and asthma, real world study shows: London, UK T ...
Pharmabiz

Molecular diagnostics market size to reach USD 38.01 billion by 2034: Polaris Market Research

Molecular diagnostics market size to reach USD 38.01 billion by 2034: Polaris Market Research: United States Thursday, February 19, 2026, 09:00 Hrs [IST] The molecular diagnostics ...
Pharmabiz

KPRDO pushes Karnataka govt to prioritize pharma trade welfare in its upcoming state budget

KPRDO pushes Karnataka govt to prioritize pharma trade welfare in its upcoming state budget: Nandita Vijayasimha, Bengaluru ...
Pharmabiz

CDSCO soon to streamline online application for WHO-GMP CoPP to boost Ease of Doing Business

Shardul Nautiyal, Mumbai Thursday, February 19, 2026, 08:00 Hrs [IST] ...
Pharmabiz

AIOCD warns of grave public health threat as AI-generated fake prescriptions fuel illegal online drug sales

AIOCD warns of grave public health threat as AI-generated fake prescriptions fuel illegal online drug sales: Peethaambaran Kunnathoor, Chennai Thursday, February 19, 2026, 08:00 H ...
Pharmabiz

PCI asks pharmacy institutions to conduct Pharma Anveshan Programme on March 6

PCI asks pharmacy institutions to conduct Pharma Anveshan Programme on March 6: Our Bureau, New Delhi Thursday, February 19, 2026, 08:00 Hrs [IST] As part of celebrating the Natio ...
Pharmabiz

Newron secures up to EUR 38 million to advance its ENIGMA-TRS pivotal phase III programme

Newron secures up to EUR 38 million to advance its ENIGMA-TRS pivotal phase III programme: Milan, Italy Wednesday, February 18, 2026, 18:00 Hrs [IST] Newron Pharmaceuticals SpA, a ...
Pharmabiz

Kotak Alts invests Rs. 400 million in Zeroharm Sciences

Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), which invests in early to growth stage life sciences and healthcare businesses, has made an ...
Pharmabiz

IP Alliance to host the 11th Global Pharmaceutical Quality Summit between Feb 23 and 24, 2026, in Mumbai

Our Bureau, Mumbai Wednesday, February 18, 2026, 17:10 Hrs [IST] ...
Pharmabiz

Sygnature Discovery announces a strategic brand relaunch to cement its status as a global drug discovery partner

Nottingham, England Wednesday, February 18, 2026, 17:00 Hrs [IST] ...
Pharmabiz

Disc Medicine receives CRL from US FDA for its NDA of bitopertin to treat erythropoietic protoporphyria

Watertown, Massachusetts Wednesday, February 18, 2026, 16:00 Hrs [IST] ...
Pharmabiz

UK MHRA launches a consultation on indefinite recognition of CE-marked medical devices

UK MHRA launches a consultation on indefinite recognition of CE-marked medical devices: United Kingdom Wednesday, February 18, 2026, 15:00 Hrs [IST] The Medicines and Healthcare p ...